Michael Mano - 28 Feb 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Role
SVP, General Counsel&Secretary
Signature
/s/Nancy Smith as Attorney-in-Fact for Michael Mano
Issuer symbol
KPTI
Transactions as of
28 Feb 2024
Net transactions value
$0
Form type
4
Filing time
29 Feb 2024, 17:35:46 UTC
Previous filing
25 Jan 2024
Next filing
04 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Award $0 +147,000 +97% $0.000000 298,401 28 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of restricted stock units ("RSUs") pursuant to the Karyopharm Therapeutics Inc. 2022 Equity Incentive Plan, as amended. RSUs convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis. The RSUs vest in three equal annual installments beginning February 28, 2025.